An important challenge during the COVID-19 pandemic has been to understand
asymptomatic disease and the extent to which this may be a source of transmission. As …

How will the coronavirus disease 2019 (COVID-19) pandemic develop in the coming months
and years? Based on an expert survey, we examine key aspects that are likely to influence …

Background: Immunoassays for determining past SARS-CoV-2 infection have not been
systematically evaluated in vaccinated persons in comparison with unvaccinated persons …

As of November, 2021 there have been more than 250 million coronavirus disease-2019
(COVID-19) cases worldwide and more than 5 million deaths. Obstetric patients have been a …

Background Mass indoor gatherings were banned in early 2020 to prevent the spread of
SARS-CoV-2. We aimed to assess, under controlled conditions, whether infection rates …

journal homepage: www. elsevier. com/lanepe early days after infection, when most AIC
transmission studies were done. Thus, it is not surprizing that AIC were found to be …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected millions of
people globally since its first detection in late 2019. Besides humans, cats and, to some …

Coronavirus disease 2019 (COVID-19) is an infectious disease of humans caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the first case was identified …

This review considers evidence for infectious severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) presence and COVID-19 infection and illness resulting from …

With the presence of Coronavirus Disease 2019 (COVID-19) asymptomatic infections
detected, their proportion, transmission potential, and other aspects such as immunity and …